Methylprednisolone Recruiting Phase 4 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01838174A Trial of Neuroprotection With ACTH in Acute Optic Neuritis